Institutional Ownership Catalyst Pharmaceuticals, Inc. (CPRX)
This table provides information about the institutional ownership of Catalyst Pharmaceuticals, Inc. (CPRX). We have compiled data on the 385 institutions that hold shares in the stock, with a total of 103 Million shares, which have been reported (via 13F filing form) to have a value of $2.09 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
18,694,918
shares
|
$380 Million
0.01% of portfolio
|
Q2 2024
Added 5.43%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
8,765,835
shares
|
$178 Million
0.0% of portfolio
|
Q2 2025
Added 3.18%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
5,478,388
shares
|
$111 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.94%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
3,251,516
shares
|
$66.1 Million
0.1% of portfolio
|
Q2 2025
Added 9.99%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
3,183,523
shares
|
$64.8 Million
0.0% of portfolio
|
Q2 2025
Added 32.95%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Aug 14, 2025 Q2 2025 |
2,879,476
shares
|
$58.6 Million
1.44% of portfolio
|
Q2 2025
Reduced 15.86%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,866,683
shares
|
$58.3 Million
0.0% of portfolio
|
Q2 2025
Added 3.66%
|
|
|
Terry Smith
Fundsmith LLP | London, X0
|
Aug 14, 2025 Q2 2025 |
2,709,086
shares
|
$55.1 Million
0.26% of portfolio
|
Q2 2025
Added 25.93%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
2,411,660
shares
|
$49.1 Million
0.01% of portfolio
|
Q2 2025
Reduced 23.08%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
2,365,675
shares
|
$48.1 Million
0.0% of portfolio
|
Q2 2025
Added 30.59%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
1,907,521
shares
|
$38.8 Million
0.01% of portfolio
|
Q2 2025
Reduced 12.8%
|
|
|
American Century Companies Inc
Kansas City, MO |
Aug 12, 2025 Q2 2025 |
1,757,988
shares
|
$35.8 Million
0.02% of portfolio
|
Q2 2025
Added 233.86%
|
|
|
Royce & Associates LP
|
Aug 11, 2025 Q2 2025 |
1,582,862
shares
|
$32.2 Million
0.37% of portfolio
|
Q2 2025
Reduced 0.97%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
1,436,112
shares
|
$29.2 Million
0.01% of portfolio
|
Q2 2025
Added 8.24%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,304,391
shares
|
$26.5 Million
0.01% of portfolio
|
Q4 2024
Added 14.51%
|
|
|
Boston Partners
Boston, MA |
Aug 07, 2025 Q2 2025 |
1,282,722
shares
|
$26.1 Million
0.03% of portfolio
|
Q2 2025
Added 0.58%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
1,275,090
shares
|
$25.9 Million
0.0% of portfolio
|
Q2 2025
Reduced 14.2%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Aug 13, 2025 Q2 2025 |
1,223,623
shares
|
$24.9 Million
0.02% of portfolio
|
Q2 2025
Added 18.22%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
1,213,700
shares
|
$24.7 Million
0.0% of portfolio
|
Q2 2025
Added 1.17%
|
|
|
Allianz Asset Management Gmb H
Munich, 2M |
Jul 28, 2025 Q2 2025 |
1,037,811
shares
|
$21.1 Million
0.03% of portfolio
|
Q2 2025
Added 49.51%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
1,014,410
shares
|
$20.6 Million
0.02% of portfolio
|
Q2 2025
Added 33.42%
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
Aug 13, 2025 Q2 2025 |
1,009,461
shares
|
$20.5 Million
0.55% of portfolio
|
Q2 2025
Reduced 4.89%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
986,271
shares
|
$20.1 Million
0.01% of portfolio
|
Q2 2025
Added 28.42%
|
|
|
Macquarie Group LTD
Australia, C3 |
Aug 14, 2025 Q2 2025 |
905,285
shares
|
$18.4 Million
0.02% of portfolio
|
Q2 2025
Reduced 3.14%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Aug 14, 2025 Q2 2025 |
845,048
shares
|
$17.2 Million
0.01% of portfolio
|
Q2 2025
Added 91.83%
|